Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Your sleep could reveal your future health—Stanford’s new AI shows how
- Doctors warn BMI may be misleading—This simple waist measure predicts health risk better
- Early colon cancer has a new clue—and it’s not a symptom you can feel
- This kind of quick workout could be a game-changer in the fight against bowel cancer
- Killer exposed: UN reveals Cervical Cancer takes a woman’s life every two minutes
-1763561110.jpg "Image of the day: November 19, 2025")
